D.A. Davidson & Co’s Oncolytics Biotech ONCY Stock Holding History

D.A. Davidson & Co’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.9K	Buy	+14,825	New	+$12K	﹤0.01%	1597

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.68B AUM 22.33% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return

Doliver Advisors Houston, Texas $458M AUM 38.24% 1-Year Est. Return

Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Crestwood Advisors Group Boston, Massachusetts $6.76B AUM 24% 1-Year Est. Return

Valley National Advisers Bethlehem, Pennsylvania $909M AUM 22.39% 1-Year Est. Return

Cedar Mountain Advisors Lake Oswego, Oregon $590M AUM 11.27% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

D.A. Davidson & Co's ONCY Position: Q3 2026 in Review

D.A. Davidson & Co opened a new position in Oncolytics Biotech (ONCY) in Q3 2026: 14,825 shares worth $9.9K. The stake represents ﹤0.01% of the portfolio and ranks #1597 among its holdings.

17 funds tracked by Wall St. Rank hold ONCY as of Q3 2026.

D.A. Davidson & Co held 14,825 shares of Oncolytics Biotech worth $9.9K as of Q3 2026.
Oncolytics Biotech was a new D.A. Davidson & Co position in Q3 2026.
Oncolytics Biotech made up ﹤0.01% of D.A. Davidson & Co's portfolio in Q3 2026, its #1597 holding.
17 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2026.

Based on D.A. Davidson & Co's 13F filing for Q3 2026, filed 28 Oct 2026.